Investors

Presentations

Title Date Documents

The Use of Self-delivering RNAi to Enhance NK Cell Cytotoxicity - Presented at the 16th Annual Discovery on Target Conference

20th Annual Rodman & Renshaw Global Healthcare Presentation

RXi Q2 2018 Earnings Conference Call Transcript

Samcyprone (Diphenylcyclopropenone Ointment) for the Treatment of Common Warts - Presented at IID2018 – date May 18, 2018

Topical Application of Self-delivering RNAi (sd-rxRNA®) Compounds for Reduction of Hyperpigmentation - Presented at IID2018 – date May 18, 2018

RXI-109 Treatment to Reduce the Formation of Hypertrophic Dermal Scars - Presented at IID 2018 -

RXi Q1 2018 Earnings Conference Call Transcript

RXi at the NYC Oncology Investment Conference

Developing the Next Generation of Immuno-Oncology Therapeutics

RXi Q4 2017 Earnings Conference Call Transcript